Covered recipient · General Payments record
AMY C ROY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,840.16
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $919.48 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $356.40 | 13 |
| Nevro Corp. | $219.41 | 6 |
| Averitas Pharma Inc. | $77.53 | 4 |
| PAINTEQ LLC | $76.40 | 2 |
| Collegium Pharmaceutical, Inc. | $72.76 | 4 |
| FIDIA PHARMA USA INC. | $56.44 | 2 |
| Teva Pharmaceuticals USA, Inc. | $25.81 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.28 | 1 |
| Abbott Laboratories | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.45 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125113490 | CMS |
| ABBVIE INC. | $13.02 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444978 | CMS |
| ABBVIE INC. | $22.70 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444980 | CMS |
| ABBVIE INC. | $5.83 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444982 | CMS |
| ABBVIE INC. | $90.90 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444984 | CMS |
| ABBVIE INC. | $24.94 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444986 | CMS |
| ABBVIE INC. | $11.79 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444988 | CMS |
| ABBVIE INC. | $11.40 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444990 | CMS |
| ABBVIE INC. | $10.32 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444992 | CMS |
| ABBVIE INC. | $6.84 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444994 | CMS |
| ABBVIE INC. | $14.26 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444996 | CMS |
| ABBVIE INC. | $22.14 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106444998 | CMS |
| ABBVIE INC. | $0.85 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106445000 | CMS |
| ABBVIE INC. | $121.41 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106445002 | CMS |
| Averitas Pharma Inc. | $13.58 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133452716 | CMS |
| Averitas Pharma Inc. | $22.09 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133452719 | CMS |
| Averitas Pharma Inc. | $20.50 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133452724 | CMS |
| Averitas Pharma Inc. | $21.36 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133452727 | CMS |
| Boston Scientific Corporation | $19.28 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092528971 | CMS |
| Collegium Pharmaceutical, Inc. | $15.67 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135244938 | CMS |
| Collegium Pharmaceutical, Inc. | $15.72 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135264528 | CMS |
| Collegium Pharmaceutical, Inc. | $16.47 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135288141 | CMS |
| Collegium Pharmaceutical, Inc. | $24.90 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135348534 | CMS |
| Fidia Pharma USA Inc. | $30.70 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141159511 | CMS |
| Fidia Pharma USA Inc. | $25.74 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141159513 | CMS |
| Nevro Corp. | $27.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130779985 | CMS |
| Nevro Corp. | $25.09 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130779987 | CMS |
| Nevro Corp. | $73.34 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780061 | CMS |
| Nevro Corp. | $30.60 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780059 | CMS |
| Nevro Corp. | $29.10 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130780063 | CMS |
| Nevro Corp. | $33.86 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130779989 | CMS |
| PAINTEQ LLC | $57.24 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142006135 | CMS |
| PAINTEQ LLC | $19.16 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142006139 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.81 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151592795 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.